A detailed history of Corient Capital Partners, LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Corient Capital Partners, LLC holds 3,420 shares of IDXX stock, worth $1.44 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,420
Previous 3,391 0.86%
Holding current value
$1.44 Million
Previous $1.19 Million 0.84%
% of portfolio
0.09%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$325.8 - $407.78 $9,448 - $11,825
29 Added 0.86%
3,420 $1.2 Million
Q2 2022

Aug 12, 2022

BUY
$327.37 - $553.44 $164,339 - $277,826
502 Added 17.38%
3,391 $1.19 Million
Q1 2022

May 16, 2022

BUY
$466.52 - $631.01 $731,503 - $989,423
1,568 Added 118.7%
2,889 $1.58 Million
Q4 2021

Feb 11, 2022

SELL
$586.54 - $666.48 $18,769 - $21,327
-32 Reduced 2.37%
1,321 $869,000
Q3 2021

Nov 16, 2021

BUY
$621.9 - $705.76 $62,811 - $71,281
101 Added 8.07%
1,353 $841,000
Q2 2021

Aug 16, 2021

BUY
$486.36 - $637.08 $41,826 - $54,788
86 Added 7.38%
1,252 $791,000
Q1 2021

May 17, 2021

BUY
$465.18 - $551.79 $97,222 - $115,324
209 Added 21.84%
1,166 $571,000
Q4 2020

Feb 12, 2021

BUY
$383.85 - $499.87 $19,576 - $25,493
51 Added 5.63%
957 $478,000
Q3 2020

Nov 16, 2020

SELL
$334.54 - $406.31 $36,799 - $44,694
-110 Reduced 10.83%
906 $356,000
Q2 2020

Aug 14, 2020

BUY
$230.66 - $330.16 $27,679 - $39,619
120 Added 13.39%
1,016 $335,000
Q1 2020

May 06, 2020

BUY
$182.94 - $290.97 $163,914 - $260,709
896 New
896 $217,000
Q4 2019

Feb 04, 2020

SELL
$248.66 - $285.01 $202,160 - $231,713
-813 Closed
0 $0
Q3 2019

Nov 06, 2019

BUY
$260.07 - $289.93 $211,436 - $235,713
813 New
813 $221,000

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $35B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Corient Capital Partners, LLC Portfolio

Follow Corient Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.